genedrive plc (LON:GDR – Get Free Report)’s share price shot up 13.9% on Wednesday . The company traded as high as GBX 2.13 ($0.03) and last traded at GBX 2.05 ($0.03). 12,457,688 shares were traded during trading, a decline of 11% from the average session volume of 13,938,082 shares. The stock had previously closed at GBX 1.80 ($0.02).
genedrive Trading Up 16.7 %
The company has a quick ratio of 5.52, a current ratio of 1.63 and a debt-to-equity ratio of 8.57. The company has a 50-day moving average price of GBX 2.56 and a 200-day moving average price of GBX 3.01. The company has a market capitalization of £11.41 million, a price-to-earnings ratio of -45.00 and a beta of -0.04.
Insiders Place Their Bets
In related news, insider Ian David Gilham acquired 1,000,000 shares of the business’s stock in a transaction dated Wednesday, August 14th. The stock was acquired at an average price of GBX 3 ($0.04) per share, with a total value of £30,000 ($39,261.88). Company insiders own 14.75% of the company’s stock.
About genedrive
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Recommended Stories
- Five stocks we like better than genedrive
- What Does Downgrade Mean in Investing?
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- What is an Earnings Surprise?
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.